{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:50:28Z","timestamp":1767340228947},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00347-019-00978-6","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T17:03:27Z","timestamp":1569344607000},"page":"989-1004","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Konjunktivale Malignome"],"prefix":"10.1007","volume":"116","author":[{"given":"Claudia","family":"Auw-H\u00e4drich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3332\/ecancer.2012.254","volume":"6","author":"B Emmanuel","year":"2012","unstructured":"Emmanuel B, Ruder E, Lin S\u2011W et al (2012) Incidence of squamous-cell carcinoma of the conjunctiva and other eye cancers in the NIH-AARP Diet and Health Study. Ecancermedicalscience 6:254. \n                    https:\/\/doi.org\/10.3332\/ecancer.2012.254","journal-title":"Ecancermedicalscience"},{"key":"978_CR2","first-page":"73","volume":"6","author":"EC Sun","year":"1997","unstructured":"Sun EC, Fears TR, Goedert JJ (1997) Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomarkers Prev 6:73\u201377","journal-title":"Cancer. Epidemiol. Biomarkers Prev."},{"issue":"1960","key":"978_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/archopht.1992.01080160103042","volume":"110","author":"GA Lee","year":"1992","unstructured":"Lee GA, Hirst LW (1992) Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year survey. Arch Ophthalmol 110(1960):525\u2013527","journal-title":"Arch. Ophthalmol."},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/tmi.12203","volume":"18","author":"S Gichuhi","year":"2013","unstructured":"Gichuhi S, Sagoo MS, Weiss HA, Burton MJ (2013) Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health 18:1424\u20131443. \n                    https:\/\/doi.org\/10.1111\/tmi.12203","journal-title":"Trop Med Int Health"},{"key":"978_CR5","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1167\/iovs.08-1768","volume":"49","author":"LD Sj\u00f6","year":"2008","unstructured":"Sj\u00f6 LD, Ralfkiaer E, Prause JU et\u00a0al (2008) Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest Ophthalmol Vis Sci 49:3283\u20133288. \n                    https:\/\/doi.org\/10.1167\/iovs.08-1768","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"978_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0002-9394(02)02288-2","volume":"135","author":"G-P Yu","year":"2003","unstructured":"Yu G\u2011P, Hu D\u2011N, McCormick S, Finger PT (2003) Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 135:800\u2013806","journal-title":"Am J Ophthalmol"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.ajo.2003.09.009","volume":"136","author":"S Tuomaala","year":"2003","unstructured":"Tuomaala S, Kivel\u00e4 T (2003) Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 136:1189\u20131190 (author reply 1190)","journal-title":"Am J Ophthalmol"},{"key":"978_CR8","volume-title":"WHO classification of tumours of the eye","author":"HE Grossniklaus","year":"2018","unstructured":"Grossniklaus HE, Eberhart CG, Kivel\u00e4 TT (2018) WHO classification of tumours of the eye, 4.\u00a0Aufl. IARC (International Agency for the Research on Cancer) Publications, Lyon","edition":"4"},{"key":"978_CR9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/bjophthalmol-2016-309219","volume":"101","author":"R Parrozzani","year":"2017","unstructured":"Parrozzani R, Frizziero L, Trainiti S et al (2017) Topical 1\u202f% 5\u2011fluoruracil as a\u00a0sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Br J Ophthalmol 101:1094\u20131099. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309219","journal-title":"Br J Ophthalmol"},{"key":"978_CR10","first-page":"441","volume":"16","author":"AE Gates","year":"2002","unstructured":"Gates AE, Kaplan LD (2002) AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 16:441\u2013451, 456, 459","journal-title":"Oncology"},{"key":"978_CR11","doi-asserted-by":"publisher","first-page":"1437, 1451","DOI":"10.1136\/bjo.2007.132852","volume":"93","author":"L Bredow","year":"2009","unstructured":"Bredow L, Martin G, Reinhard T et al (2009) Recurrent conjunctival papilloma progressing into squamous cell carcinoma with change of HPV-finding during the course. Br J Ophthalmol 93:1437, 1451. \n                    https:\/\/doi.org\/10.1136\/bjo.2007.132852","journal-title":"Br J Ophthalmol"},{"key":"978_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/1874364100802010048","volume":"2","author":"C Auw-Haedrich","year":"2008","unstructured":"Auw-Haedrich C, Martin G, Spelsberg H et al (2008) Expression of p16 in conjunctival intraepithelial neoplasia does not correlate with HPV-infection. Open Ophthalmol\u00a0J 2:48\u201356. \n                    https:\/\/doi.org\/10.2174\/1874364100802010048","journal-title":"Open Ophthalmol J"},{"key":"978_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1309\/RVUP-QMU3-5X6W-3CQ1","volume":"117","author":"H-L Eng","year":"2002","unstructured":"Eng H\u2011L, Lin T\u2011M, Chen S\u2011Y et al (2002) Failure to detect human papillomavirus DNA in malignant epithelial neoplasms of conjunctiva by polymerase chain reaction. Am J Clin Pathol 117:429\u2013436. \n                    https:\/\/doi.org\/10.1309\/RVUP-QMU3-5X6W-3CQ1","journal-title":"Am J Clin Pathol"},{"key":"978_CR14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00347-003-0809-z","volume":"100","author":"C Kallen","year":"2003","unstructured":"Kallen C, Reinhard T, Schilgen G et\u00a0al (2003) Atopic keratoconjunctivitis: probably a\u00a0risk factor for the development of conjuntival carcinoma. Ophthalmologe 100:808\u2013814. \n                    https:\/\/doi.org\/10.1007\/s00347-003-0809-z","journal-title":"Ophthalmologe"},{"key":"978_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/bjo.86.2.168","volume":"86","author":"PA McKelvie","year":"2002","unstructured":"McKelvie PA, Daniell M, McNab A et\u00a0al (2002) Squamous cell carcinoma of the conjunctiva: a\u00a0series of 26 cases. Br J Ophthalmol 86:168\u2013173","journal-title":"Br J Ophthalmol"},{"key":"978_CR16","volume-title":"TNM: Klassifikation maligner Tumoren","author":"C Wittekind","year":"2017","unstructured":"Wittekind C (2017) TNM: Klassifikation maligner Tumoren, 8.\u00a0Aufl. Wiley, Weinheim","edition":"8"},{"key":"978_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/ICO.0000000000000766","volume":"35","author":"AN Siedlecki","year":"2016","unstructured":"Siedlecki AN, Tapp S, Tosteson ANA et al (2016) Surgery versus interferon Alpha-2b treatment strategies for ocular surface squamous neoplasia: a literature-based decision analysis. Cornea 35:613\u2013618. \n                    https:\/\/doi.org\/10.1097\/ICO.0000000000000766","journal-title":"Cornea"},{"key":"978_CR18","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1001\/archophthalmol.2012.2515","volume":"130","author":"T El-Sawy","year":"2012","unstructured":"El-Sawy T, Sabichi AL, Myers JN et al (2012) Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma. Arch Ophthalmol 130:1608\u20131611. \n                    https:\/\/doi.org\/10.1001\/archophthalmol.2012.2515","journal-title":"Arch. Ophthalmol."},{"key":"978_CR19","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.ophtha.2012.04.022","volume":"119","author":"A Galor","year":"2012","unstructured":"Galor A, Karp CL, Oellers P et\u00a0al (2012) Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. Ophthalmology 119:1974\u20131981. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2012.04.022","journal-title":"Ophthalmology"},{"key":"978_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/aos.12743","volume":"93","author":"I Ramberg","year":"2015","unstructured":"Ramberg I, Heegaard S, Prause JU et\u00a0al (2015) Squamous cell dysplasia and carcinoma of the conjunctiva. A nationwide, retrospective, epidemiological study of Danish patients. Acta Ophthalmol (Copenh) 93:663\u2013666. \n                    https:\/\/doi.org\/10.1111\/aos.12743","journal-title":"Acta Ophthalmol. (Copenh)"},{"key":"978_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0161-6420(88)33180-5","volume":"95","author":"KF Tabbara","year":"1988","unstructured":"Tabbara KF, Kersten R, Daouk N, Blodi FC (1988) Metastatic squamous cell carcinoma of the conjunctiva. Ophthalmology 95:318\u2013321","journal-title":"Ophthalmology"},{"key":"978_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1055\/s-0029-1246068","volume":"228","author":"H Westekemper","year":"2011","unstructured":"Westekemper H, Schallenberg M, Tomaszewski A et\u00a0al (2011) Malignant epibulbar tumours: new strategies in diagnostics and therapy. Klin Monatsbl Augenheilkd 228:780\u2013792. \n                    https:\/\/doi.org\/10.1055\/s-0029-1246068","journal-title":"Klin. Monatsbl. Augenheilkd."},{"key":"978_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0161-6420(89)32920-4","volume":"96","author":"FA Jakobiec","year":"1989","unstructured":"Jakobiec FA, Folberg R, Iwamoto T (1989) Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 96:147\u2013166","journal-title":"Ophthalmology"},{"key":"978_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.22608\/APO.201710","volume":"6","author":"CL Shields","year":"2017","unstructured":"Shields CL, Chien JL, Surakiatchanukul T et al (2017) Conjunctival tumors: review of clinical features, risks, biomarkers, and outcomes--the 2017 J. Donald M. Gass lecture. Asia Pac J Ophthalmol 6:109\u2013120. \n                    https:\/\/doi.org\/10.22608\/APO.201710","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"978_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1442-9071.2008.01888.x","volume":"36","author":"B Damato","year":"2008","unstructured":"Damato B, Coupland SE (2008) Conjunctival melanoma and melanosis: a\u00a0reappraisal of terminology, classification and staging. Clin Exp Ophthalmol 36:786\u2013795. \n                    https:\/\/doi.org\/10.1111\/j.1442-9071.2008.01888.x","journal-title":"Clin. Exp. Ophthalmol."},{"key":"978_CR26","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1167\/iovs.14-14901","volume":"55","author":"AE Koopmans","year":"2014","unstructured":"Koopmans AE, Ober K, Dubbink HJ et\u00a0al (2014) Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci 55:6024\u20136030. \n                    https:\/\/doi.org\/10.1167\/iovs.14-14901","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"978_CR27","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","volume":"19","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Westekemper H, Murali R et\u00a0al (2013) Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas. Clin Cancer Res 19:3143\u20133152. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0163","journal-title":"Clin. Cancer. Res."},{"key":"978_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00417-005-0035-2","volume":"244","author":"M Pache","year":"2006","unstructured":"Pache M, Glatz-Krieger K, Sauter G, Meyer P (2006) Expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva. Graefes Arch Clin Exp Ophthalmol 244:113\u2013117. \n                    https:\/\/doi.org\/10.1007\/s00417-005-0035-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"978_CR29","first-page":"244","volume":"27","author":"C Auw-H\u00e4drich","year":"2006","unstructured":"Auw-H\u00e4drich C, Reinhard T (2006) Bindehautmelanom. Z Prakt Augenheilkd 27:244\u2013250","journal-title":"Z Prakt Augenheilkd"},{"key":"978_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.survophthal.2016.06.001","volume":"62","author":"GK Vora","year":"2017","unstructured":"Vora GK, Demirci H, Marr B, Mruthyunjaya P (2017) Advances in the management of conjunctival melanoma. Surv Ophthalmol 62:26\u201342. \n                    https:\/\/doi.org\/10.1016\/j.survophthal.2016.06.001","journal-title":"Surv Ophthalmol"},{"key":"978_CR31","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00417-017-3754-2","volume":"255","author":"I Kikuchi","year":"2017","unstructured":"Kikuchi I, Kase S, Ishijima K, Ishida S (2017) Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection. Graefes Arch Clin Exp Ophthalmol 255:2271\u20132276. \n                    https:\/\/doi.org\/10.1007\/s00417-017-3754-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"978_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/eye.2008.154","volume":"23","author":"B Damato","year":"2009","unstructured":"Damato B, Coupland SE (2009) An audit of conjunctival melanoma treatment in Liverpool. Eye 23:801\u2013809. \n                    https:\/\/doi.org\/10.1038\/eye.2008.154","journal-title":"Eye"},{"key":"978_CR33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00417-005-0093-5","volume":"244","author":"H Wuestemeyer","year":"2006","unstructured":"Wuestemeyer H, Sauerwein W, Meller D et\u00a0al (2006) Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol 244:438\u2013446. \n                    https:\/\/doi.org\/10.1007\/s00417-005-0093-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"978_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4172\/2155-9570.1000322","volume":"5","author":"M Pahlitzsch","year":"2014","unstructured":"Pahlitzsch M, Bertelmann E, Mai C (2014) Conjunctival melanoma and BRAF inhibitor therapy. J\u00a0Clin Exp Ophthalmol 5:322","journal-title":"J Clin Exp Ophthalmol"},{"key":"978_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/IOP.0b013e3182611670","volume":"28","author":"CL Shields","year":"2012","unstructured":"Shields CL, Kaliki S, Al-Dahmash SA et al (2012) American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes. Ophthal Plast Reconstr Surg 28:313\u2013323. \n                    https:\/\/doi.org\/10.1097\/IOP.0b013e3182611670","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"978_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/aos.13007","volume":"94","author":"A-C Larsen","year":"2016","unstructured":"Larsen A\u2011C, Dahl C, Dahmcke CM et al (2016) BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions. Acta Ophthalmol 94:463\u2013470. \n                    https:\/\/doi.org\/10.1111\/aos.13007","journal-title":"Acta. Ophthalmol."},{"key":"978_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00347-018-0664-6","volume":"115","author":"J-P Glossmann","year":"2018","unstructured":"Glossmann J\u2011P, Skoetz N, Starbatty B et al (2018) Conjunctival melanoma\u202f: Standard operating procedures in diagnosis, treatment and follow-up care. Ophthalmologe 115:489\u2013498. \n                    https:\/\/doi.org\/10.1007\/s00347-018-0664-6","journal-title":"Ophthalmologe"},{"key":"978_CR38","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/S0161-6420(98)98024-1","volume":"105","author":"SE Coupland","year":"1998","unstructured":"Coupland SE, Krause L, Delecluse HJ et\u00a0al (1998) Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 105:1430\u20131441. \n                    https:\/\/doi.org\/10.1016\/S0161-6420(98)98024-1","journal-title":"Ophthalmology"},{"key":"978_CR39","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.survophthal.2015.05.001","volume":"60","author":"MM Kirkegaard","year":"2015","unstructured":"Kirkegaard MM, Coupland SE, Prause JU, Heegaard S (2015) Malignant lymphoma of the conjunctiva. Surv Ophthalmol 60:444\u2013458. \n                    https:\/\/doi.org\/10.1016\/j.survophthal.2015.05.001","journal-title":"Surv Ophthalmol"},{"key":"978_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/aos.12189","volume":"5","author":"PK Rasmussen","year":"2013","unstructured":"Rasmussen PK (2013) Diffuse large B\u2011cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features. Acta Ophthalmol 5:1\u201327. \n                    https:\/\/doi.org\/10.1111\/aos.12189\n                    \n                   (91 Thesis)","journal-title":"Acta Ophthalmol"},{"key":"978_CR41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamaophthalmol.2015.6122","volume":"134","author":"MM Kirkegaard","year":"2016","unstructured":"Kirkegaard MM, Rasmussen PK, Coupland SE et\u00a0al (2016) Conjunctival lymphoma\u2014an international multicenter retrospective study. Jama Ophthalmol 134:406\u2013414. \n                    https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.6122","journal-title":"Jama Ophthalmol"},{"key":"978_CR42","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1136\/bjophthalmol-2013-304847","volume":"98","author":"MC Sniegowski","year":"2014","unstructured":"Sniegowski MC, Roberts D, Bakhoum M et\u00a0al (2014) Ocular adnexal lymphoma: validation of American Joint Committee on Cancer seventh edition staging guidelines. Br J Ophthalmol 98:1255\u20131260. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304847","journal-title":"Br J Ophthalmol"},{"key":"978_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/01676830.2013.842257","volume":"33","author":"S Rath","year":"2014","unstructured":"Rath S, Connors JM, Dolman PJ et al (2014) Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphoma. Orbit 33:23\u201328. \n                    https:\/\/doi.org\/10.3109\/01676830.2013.842257","journal-title":"Orbit"},{"key":"978_CR44","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00417-015-2932-3","volume":"253","author":"D Suesskind","year":"2015","unstructured":"Suesskind D, Ziemssen F, Rohrbach JM (2015) Conjunctival amyloidosis\u2014clinical and histopathologic features. Graefes Arch Clin Exp Ophthalmol 253:1377\u20131383. \n                    https:\/\/doi.org\/10.1007\/s00417-015-2932-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"978_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ophtha.2017.05.037","volume":"125","author":"MT Yen","year":"2018","unstructured":"Yen MT, Bilyk JR, Wladis EJ et\u00a0al (2018) Treatments for ocular adnexal lymphoma: a report by the American Academy of Ophthalmology. Ophthalmology 125:127\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.037","journal-title":"Ophthalmology"},{"key":"978_CR46","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/hed.24717","volume":"39","author":"CC Pinnix","year":"2017","unstructured":"Pinnix CC, Dabaja BS, Milgrom SA et al (2017) Ultra-low-dose radiotherapy for definitive management of ocular adnexal B\u2011cell lymphoma. Head Neck 39:1095\u20131100. \n                    https:\/\/doi.org\/10.1002\/hed.24717","journal-title":"Head Neck"},{"key":"978_CR47","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S1470-2045(12)70481-3","volume":"13","author":"N Schmitz","year":"2012","unstructured":"Schmitz N, Nickelsen M, Ziepert M et al (2012) Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B\u2011cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). Lancet Oncol 13:1250\u20131259. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(12)70481-3","journal-title":"Lancet Oncol"},{"key":"978_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2141.2012.09174.x","volume":"158","author":"CH Geisler","year":"2012","unstructured":"Geisler CH, Kolstad A, Laurell A et al (2012) Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur. Br J Haematol 158:355\u2013362. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09174.x","journal-title":"Br J Haematol"},{"key":"978_CR49","first-page":"40","volume-title":"WHO classification of tumours of the eye","author":"SE Coupland","year":"2018","unstructured":"Coupland SE, Heegaard S, Loeffler KU et\u00a0al (2018) Haematolymphoid tumours of the conjunctiva and caruncle. In: Grossniklaus HE, Eberhart CG, Kivel\u00e4 TT (Hrsg) WHO classification of tumours of the eye, 4.\u00a0Aufl. International Agency for Research on Cancer, Lyon, S\u00a040\u201341","edition":"4"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-00978-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-019-00978-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-00978-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T23:30:29Z","timestamp":1600817429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-019-00978-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s00347-019-00978-6","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,24]]},"assertion":[{"value":"24 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>C.\u00a0Auw-H\u00e4drich<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Angestellte Ophthalmologin, Ober\u00e4rztin, Klinik f\u00fcr Augenheilkunde, Universit\u00e4t Freiburg. <b>T.\u00a0Reinhard<\/b>: A. Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: AAD-Tagung (Honorar + Reise-\/\u00dcbernachtungsgeb\u00fchren) | DOC-Tagung (Teilnahmegeb\u00fchren) | Sitzung des Wissenschaftlichen Beirats der Bundes\u00e4rztekammer (Honorar + Teilnahmegeb\u00fchren) | Redaktionskonferenz des Deutschen \u00c4rzteblatts (Reise-\/\u00dcbernachtungsgeb\u00fchren). \u2013 B. Nichtfinanzielle Interessen: \u00c4rztlicher Direktor der Universit\u00e4ts-Augenklinik Freiburg seit 2003 | Generalsekret\u00e4r der Deutschen Ophthalmologischen Gesellschaft (DOG) seit 2014, Mitglied des Gesamtpr\u00e4sidiums seit 2008, Mitglied des Gesch\u00e4ftsf\u00fchrenden Pr\u00e4sidiums seit 2009, Pr\u00e4sident 2010\u20132011, Vizepr\u00e4sident 2009\u20132010, 2011\u20132012, Schatzmeister 2012\u20132014 | Vorstandsmitglied der DOG-Sektion Kornea seit 2001 | Mitglied des Wissenschaftlichen Beirats der Bundes\u00e4rztekammer seit 2006 | Fachredakteur \u201eDeutsches \u00c4rzteblatt\u201c seit 2010 | Mitglied der Programmkommission des AAD-Kongresses seit 2015 | Sprecher der DOG-Sektion Gewebetransplantation und Biotechnologie (vormals Arbeitsgemeinschaft Deutscher Hornhautbanken) 2008\u20132014 | Mitglied des Vorstands von EUCornea 2009\u20132013 | Vorstandsmitglied von Bio Implant Services (BIS, Leiden\/Niederlande) 2006\u20132009 | Prodekan der Medizinischen Fakult\u00e4t Freiburg 2006\u20132009 | Vorsitzender der Freiburger Medizinischen Gesellschaft 2004\u20132007 | Sprecher des Augennetz S\u00fcdbaden 2008\u20132011 (Gr\u00fcndung 2008) | Gr\u00fcndung des Eyenet Baden-W\u00fcrttemberg 2008 | Gr\u00fcndung einer Augennotfallsprechstunde mit der KVBW | im Stadtkreis Freiburg und mittlerweile weiteren 6 Stadt- und Landkreisen 2010 | Aufbau und Leitung der LIONS Hornhautbank NRW 1994\u20132003 | Aufbau und Leitung der LIONS Hornhautbank Baden-W\u00fcrttemberg 2003\u20132005 | Mitglied des Siftungsrats Europ\u00e4ischer Gewebebanken seit 2009 | Vorstandsmitglied des Bundes der Deutschen Ophthalmochirurgen (BDOC) 2006\u20132009 | Rubrik-\/Sektionsherausgeber \u201eDer Ophthalmologe\u201c seit 2006 | Sektionsherausgeber European Manual of Ophthalmology 2003\u20132011 | Gr\u00fcnder und Leiter des Ophthalmo-Update 2011\u20132016 | Mitglied und Sprecher des Kuratoriums f\u00fcr die Verleihung des Hodeige-Preises ab 2014 | Mitherausgeber der Klinischen Monatsbl\u00e4tter f\u00fcr Augenheilkunde seit 2018.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}}]}}